- Home
- WMK vs HCM Comparison
WMK vs HCM Comparison
Compare WMK & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- HCM
- Stock Information
- Founded
- WMK 1912
- HCM 2000
- Country
- WMK United States
- HCM Hong Kong
- Employees
- WMK N/A
- HCM N/A
- Industry
- WMK Food Chains
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- WMK Consumer Staples
- HCM Health Care
- Exchange
- WMK Nasdaq
- HCM Nasdaq
- Market Cap
- WMK 2.2B
- HCM 2.5B
- IPO Year
- WMK N/A
- HCM N/A
- Fundamental
- Price
- WMK $80.68
- HCM $14.21
- Analyst Decision
- WMK
- HCM Hold
- Analyst Count
- WMK 0
- HCM 1
- Target Price
- WMK N/A
- HCM $19.00
- AVG Volume (30 Days)
- WMK 135.8K
- HCM 82.7K
- Earning Date
- WMK 05-07-2025
- HCM 03-19-2025
- Dividend Yield
- WMK 1.72%
- HCM N/A
- EPS Growth
- WMK 6.00
- HCM N/A
- EPS
- WMK 3.99
- HCM 0.04
- Revenue
- WMK $4,810,301,000.00
- HCM $630,201,000.00
- Revenue This Year
- WMK N/A
- HCM $14.86
- Revenue Next Year
- WMK N/A
- HCM $19.54
- P/E Ratio
- WMK $20.26
- HCM $68.70
- Revenue Growth
- WMK 1.70
- HCM N/A
- 52 Week Low
- WMK $60.93
- HCM $11.51
- 52 Week High
- WMK $88.60
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- WMK 44.46
- HCM 45.83
- Support Level
- WMK $80.81
- HCM $14.18
- Resistance Level
- WMK $90.23
- HCM $14.84
- Average True Range (ATR)
- WMK 2.60
- HCM 0.57
- MACD
- WMK -0.52
- HCM -0.03
- Stochastic Oscillator
- WMK 16.10
- HCM 1.94
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.